CORPORATE INFO FOR INVESTORS OUR PRODUCTS BUSINESS DEVELOPMENT CONTACT US HOME

Menu

Financial Statements
  • Financial Reports
  • Securities Filing
      
    Investor Resources
  • Fact Sheet
  • Presentations
  • Analyst Coverage
  • Calendar of Events
  • FAQ
  • Shareholder
         Services
  • Investor Kit
  • Investor Information

    News
  • Press Releases
  • Corporate News
  • Awards
    •   PRESS RELEASES  
    COMMUNIQUÉS DE PRESSE (Français)

    2013  |  2012  |  2011  |    2010  |  2009  |  2008  |  2007  |  2006  |   2005  |   2004  |   2003  |   2002  |   2001  |   2000  |   1999  |   1998  |   1997  |  


    December 20, 2010
    PALADIN AND ISOTECHNIKA SUBMIT VOCLERA(TM) (VOCLOSPORIN) FOR CANADIAN APPROVAL
    (Also in PDF format)
    December 16, 2010
    PALADIN LABS AND PROSTRAKAN ANNOUNCE NEW STRATEGIC RELATIONSHIP AND FINANCING AGREEMENT
    (Also in PDF format)
    December 1, 2010
    PALADIN LABS INC.: RECALL AND WITHDRAWAL OF DARVON-N(R) (DEXTROPROPOXYPHENE) IN CANADA
    (Also in PDF format)
    November 4, 2010
    PALADIN REPORTS THIRD QUARTER 2010 FINANCIAL RESULTS
    (Also in PDF format)
    October 28, 2010
    NOTICE OF PALADIN LABS' THIRD QUARTER 2010 RESULTS CONFERENCE CALL
    (Also in PDF format)
    October 14, 2010
    LABOPHARM AND PALADIN ANNOUNCE EXPANSION OF COMMERCIAL RELATIONSHIP
    (Also in PDF format)
    October 13, 2010
    PALADIN TO PRESENT AT THE TD NEWCREST SMALL CAP INVESTORS CONFERENCE IN TORONTO
    (Also in PDF format)
    September 30, 2010
    PALADIN TO PRESENT AT THE BIO-CONTACT CONFERENCE IN QUEBEC CITY
    (Also in PDF format)
    September 15, 2010
    PALADIN TO PRESENT AT THE UBS GLOBAL LIFE SCIENCES CONFERENCE IN NEW YORK CITY
    (Also in PDF format)
    August 5, 2010
    PALADIN REPORTS RECORD SECOND QUARTER 2010 FINANCIAL RESULTS
    (Also in PDF format)
    July 29, 2010
    NOTICE OF PALADIN LABS' 2010 SECOND QUARTER RESULTS CONFERENCE CALL
    (Also in PDF format)
    June 8, 2010
    PALADIN TO PRESENT AT THE NEEDHAM AND JEFFERIES CONFERENCES IN NEW YORK CITY
    (Also in PDF format)
    May 6, 2010
    PALADIN REPORTS 2010 RECORD FIRST QUARTER FINANCIAL RESULTS
    (Also in PDF format)
    April 29, 2010
    NOTICE OF PALADIN LABS' 2010 FIRST QUARTER RESULTS CONFERENCE CALL
    (Also in PDF format)
    April 6, 2010
    PALADIN LABS OBTAINS CANADIAN APPROVAL FOR SEASONIQUE(R)
    (Also in PDF format)
    March 16, 2010
    PALADIN MAKES FIRST STEP INTO EMERGING MARKETS THROUGH STRATEGIC INVESTMENT IN PHARMAPLAN
    (Also in PDF format)
    March 3, 2010
    PALADIN AND SPEPHARM ANNOUNCE NEW STRATEGIC RELATIONSHIP AND FINANCING
    (Also in PDF format)
    March 1, 2010
    PALADIN ANNOUNCES NORMAL COURSE ISSUER BID AND AUTOMATIC SHARE PURCHASE PLAN
    (Also in PDF format)
    February 25, 2010
    BTG AND PALADIN COMPLETE AGREEMENT FOR DIGIFAB FOR THE TREATMENT OF DIGOXIN TOXICITY
    (Also in PDF format)
    February 25, 2010
    PALADIN REPORTS FOURTEENTH CONSECUTIVE YEAR OF RECORD REVENUES
    (Also in PDF format)
    February 23, 2010
    PALADIN TO PRESENT AT THE RBC CAPITAL MARKETS HEALTHCARE CONFERENCE IN NEW YORK CITY
    (Also in PDF format)
    February 18, 2010
    NOTICE OF PALADIN LABS' 2009 FOURTH QUARTER RESULTS CONFERENCE CALL
    (Also in PDF format)
    February 18, 2010
    PALADIN LABS ANNOUNCES AMENDMENT TO R&D AGREEMENT WITH ISOTECHNIKA PHARMA INC.
    (Also in PDF format)
    February 4, 2010
    PALADIN GRANTED PRIORITY REVIEW STATUS FOR ABSTRAL(R) BY HEALTH CANADA
    (Also in PDF format)




    HOME | SITE MAP | LEGAL DISCLAIMER